Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 502816 | ISIN: GB0009223206 | Ticker-Symbol: NPW1
Tradegate
23.04.24
09:30 Uhr
11,560 Euro
-0,160
-1,37 %
1-Jahres-Chart
SMITH & NEPHEW PLC Chart 1 Jahr
5-Tage-Chart
SMITH & NEPHEW PLC 5-Tage-Chart
RealtimeGeldBriefZeit
11,48011,79523.04.
11,63511,80523.04.

Aktuelle News zur SMITH & NEPHEW Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSMITH & NEPHEW PLC - 6-K, Report of foreign issuer2
DiSmith & Nephew Plc - Timing of Smith+Nephew Q1 2024 Trading Report2
DoSmith & Nephew UK Ltd: Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention237Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group...
► Artikel lesen
11.04.Smith+Nephew (SNN) Expands in Australia With New Alliance26
09.04.Smith & Nephew UK Ltd: Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT solution in Australia139
08.04.Here's Why You Should Invest in Smith & Nephew plc (SNN)168
04.04.Smith & Nephew UK Ltd: Smith+Nephew's PICO Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)340Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE)...
► Artikel lesen
02.04.Smith & Nephew Plc - Total Voting Rights3
02.04.Smith & Nephew Plc - Director/PDMR Shareholding3
01.04.Smith+Nephew rolls out new chronic wound treatment tech4
01.04.Smith & Nephew UK Ltd: Smith+Nephew introduces the RENASYS EDGE Negative Pressure Wound Therapy System - an exciting new option in home-based care for patients living with chronic wounds3
28.03.Dividendenbekanntmachungen (28.03.2024)13.076 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ACOM CO LTD  JP3108600002  6 JPY  0,0366 EUR  ADVANEX INC  JP3213400009  20 JPY  0,1222 EUR  AICA KOGYO CO LTD  JP3100800006  59 JPY  0...
► Artikel lesen
28.03.Smith & Nephew goes ex dividend Monday5
28.03.SMITH & NEPHEW PLC - 6-K, Report of foreign issuer2
28.03.Smith & Nephew CFO designate John Rogers to start next week5
28.03.Smith+Nephew: John Rogers To Join Board As Executive Director And CFO On 1 April267LONDON (dpa-AFX) - Medical technology company Smith+Nephew (SN.L, SNN) said that John Rogers will join the Board as an Executive Director and Chief Financial Officer on 1 April 2024, succeeding...
► Artikel lesen
28.03.Smith & Nephew Plc - Directorate Change5
25.03.Smith & Nephew UK Ltd: Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner254Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC - the world's premier mixed martial...
► Artikel lesen
20.03.SMITH & NEPHEW PLC - 8-A12B, Registration of securities3
20.03.SMITH & NEPHEW PLC - 6-K, Report of foreign issuer2
Seite:  Weiter >>
128 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1